戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 or Quil-A did not sensitize mice to M. bovis purified protein derivative.
2 e stimulated with DEP and M. tuberculosis or purified protein derivative.
3 zyme-linked immunospot responses against BCG purified protein derivative.
4  in greater numbers than T cells reactive to purified protein derivative.
5 red to responses induced by M. bovis-derived purified protein derivative.
6 following restimulation with M. tuberculosis purified protein derivative.
7 call antigen response by PBMCs to tuberculin purified protein derivative.
8               However, 48 h after tuberculin purified protein derivative administration in the ipsila
9 to MOG-35-55 peptide, and to a lesser degree purified protein derivative and Con A, but had no inhibi
10 L-2 production after both Mycobacteria bovis purified protein derivative and Schistosoma mansoni egg
11 +-T-cell activation than the soluble antigen purified protein derivative and that these cells are act
12 gamma release was significantly reduced when purified protein derivative- and Ag85B-specific CD4(+) T
13 d toward the rESAT-6-CFP10 fusion protein or purified protein derivative are comparable and that reca
14 uate its potential to replace tuberculin, or purified protein derivative, as the rapid diagnostic of
15 predictors of survival were found: anergy to purified protein derivative, atypical chest roentgenogra
16          This relationship was restricted to purified protein derivative because maternal infection s
17 NP-modified autologous melanoma cells and to purified protein derivative developed in almost all pati
18                                              Purified protein derivative-driven T cell IFN-gamma prod
19                                              Purified protein derivative ELISPOT responses increased
20 in skin test, and (4) Battey skin test using purified protein derivative from the Battey bacillus.
21 memory cells specific for tetanus toxoid and purified protein derivative in 18 healthy individuals an
22 onse to bead-immobilized Mycobacterium bovis-purified protein derivative in aged mice.
23                              When exposed to purified protein derivative in vitro, young and old CD11
24 gens can overcome specificity limitations of purified protein derivatives in the detection of bovine
25  the expression of I kappa B-alpha mRNA, and purified protein derivative induced the activation of NF
26 Further, M. tuberculosis and its tuberculin, purified protein derivative, induced the degradation of
27                                  Conversely, purified protein derivative-induced (but not concanavali
28        The production of M. tuberculosis and purified protein derivative-induced IFN-gamma, TNF-alpha
29 gamma response to Mycobacterium tuberculosis purified protein derivative (Mtb PPD) in UK adolescents,
30           Compared with those in tuberculin (purified protein derivative)-negative control subjects,
31                   T cells were expanded from purified protein derivative-negative controls, persons w
32 ,300 compared with 1/16,000 +/- 7,000 in six purified protein derivative-negative controls.
33 nonuclear cells from 15/26 sarcoidosis, 1/24 purified-protein-derivative-negative (PPD-) (P < 0.0001,
34 ng 10 tuberculosis (TB)-infected subjects, 8 purified-protein-derivative-negative subjects, and 7 pur
35       The induction of TNF-alpha and IL-1 by purified protein derivative of M. tuberculosis was signi
36                        Upon stimulation with purified protein derivative of M. tuberculosis, CD4+ T c
37  antigen and the level is as high as that to purified protein derivative of M. tuberculosis.
38 nylate cyclase of Bordetella pertussis), and purified protein derivative of M. tuberculosis.
39 ssociated with a reduced Mantoux response to purified protein derivative of M. tuberculosis: 60% of t
40 CBA mice by embolization of beads coupled to purified protein derivative of Mycobacteria tuberculosis
41 by embolizing Sepharose beads coupled to the purified protein derivative of Mycobacterium bovis or so
42 production of IFN-gamma after challenge with purified protein derivative of Mycobacterium bovis.
43 increased the in vitro cytokine responses to purified protein derivative of Mycobacterium tuberculosi
44 cells), much weaker than the response to the purified protein derivative of Mycobacterium tuberculosi
45 ayed-type hypersensitivity (DTH) response to purified protein derivative of tuberculin (PPD), the exp
46  cells specific for 2 other common antigens: purified protein derivative of tuberculin and Candida al
47                               Polyclonal and purified protein derivative of tuburculin-specific T-cel
48 igated by T cell proliferation to tuberculin purified protein derivative or allogeneic responses to F
49 as induced by bead-immobilized mycobacterial purified protein derivative or Schistosoma mansoni egg a
50 nge of primed mice with either mycobacterial purified protein derivative or schistosomal egg Ag-coate
51 , unlike the mouse system, supernatants from purified protein derivative- or concanavalin A-stimulate
52 ensitized CBA/J mice with Mycobacteria bovis purified protein derivative- or Schistosoma mansoni egg
53 .v. challenge with either Mycobacteria bovis purified protein derivative- or Schistosoma mansoni egg
54 n in response to BCG lux (P < 0.0001) and to purified protein derivative (P = 0.0001).
55 ure filtrate protein-10 (CFP10) are found in purified protein derivative positive donors, suggesting
56 absence of anti-LipC antibodies in sera from purified protein derivative-positive (PPD+) healthy subj
57 heral blood mononuclear cells of a number of purified protein derivative-positive (PPD+) human donors
58 cited pluripotent CD4 and CD8 T responses in purified protein derivative-positive donor PBMCs.
59 this is the immunodominant response for this purified protein derivative-positive donor.
60  in the context of host responses in healthy purified protein derivative-positive donors and infected
61 les for their ability to stimulate PBMC from purified protein derivative-positive healthy individuals
62 cited strong Th1 T cell responses in healthy purified protein derivative-positive human PBMC and in m
63 peripheral blood mononuclear cells in 70% of purified protein derivative-positive individuals without
64                                       In one purified protein derivative-positive subject, 192 clones
65 e effector cell frequency among five healthy purified protein derivative-positive subjects was 1/7,60
66 ) TB(+) patients tested but not in sera from purified-protein derivative-positive healthy controls, s
67                         Nonadherent cells of purified-protein-derivative-positive donors mediated equ
68 a pigs were frequently identified in healthy purified-protein-derivative-positive or BCG-vaccinated i
69 -protein-derivative-negative subjects, and 7 purified-protein-derivative-positive subjects.
70 y peripheral blood leukocytes after M. avium purified protein derivative PPD antigen stimulation show
71 with the stability of skin test responses to purified protein derivative (PPD) and candida antigens i
72 /chemokine microenvironment before and after purified protein derivative (PPD) and mannosilated lipoa
73     Whole-blood samples were stimulated with purified protein derivative (PPD) and phytohemagglutinin
74  pathogen antigens (Ags), Mycobacteria bovis purified protein derivative (PPD) and Schistosoma manson
75 dritic cells infected with TB or pulsed with purified protein derivative (PPD) but did not respond to
76 aradoxical responses and received tuberculin purified protein derivative (PPD) in Group 1 had their t
77 lar lavage (BAL) fluid after incubation with purified protein derivative (PPD) in human immunodeficie
78          T cell blastogenesis in response to purified protein derivative (PPD) in PBMCs of TB patient
79 Brugia malayi antigen (BMA) or mycobacterial purified protein derivative (PPD) in the presence of neu
80 e examined in response to concanavalin A and purified protein derivative (PPD) in vitro.
81 roliferate in response to concanavalin A and purified protein derivative (PPD) in vitro.
82  To investigate this, we injected tuberculin purified protein derivative (PPD) into the skin of immun
83                                              Purified protein derivative (PPD) is a widely used reage
84 ) HIV-seronegative patients had reactions to purified protein derivative (PPD) of > or = 2 mm (OR = 0
85 ranulomas were elicited by beads coated with purified protein derivative (PPD) of Mycobacteria bovis
86 ced by embolizing Sepharose beads coupled to purified protein derivative (PPD) of Mycobacterium bovis
87 d mice by embolization with beads coupled to purified protein derivative (PPD) of Mycobacterium bovis
88 We have used human CD4+ T cells specific for purified protein derivative (PPD) of Mycobacterium tuber
89 r delayed-type hypersensitivity responses to purified protein derivative (PPD) of tuberculin.
90 -vaccinated guinea pigs were stimulated with purified protein derivative (PPD) or M. tuberculosis H37
91 nfected cattle were stimulated with M. bovis purified protein derivative (PPD) or pokeweed mitogen (P
92 m HIV-infected individuals with a history of purified protein derivative (PPD) positivity but not in
93 s were cocultured with autologous T-Regs and purified protein derivative (PPD) preprimed T-Reg-deplet
94 tive therapy trial in Uganda with an initial purified protein derivative (PPD) response < 5 mm comple
95 accination may induce persistent and booster purified protein derivative (PPD) responses that complic
96  11 (17%) of 66 with a history of a positive purified protein derivative (PPD) skin test acquired M.
97                                          The purified protein derivative (PPD) skin test has been use
98                                              Purified protein derivative (PPD) skin testing is used t
99 ination, laboratory evaluation, and standard purified protein derivative (PPD) testing (Mantoux metho
100         Delayed hypersensitivity response to purified protein derivative (PPD) tuberculin and mumps a
101 cobacterium avium sensitin (MAS) RS 10/2 and purified protein derivative (PPD) was conducted on patie
102 human experimental system whereby tuberculin purified protein derivative (PPD) was injected into the
103  respectively, in response to MTB (H37Ra) or purified protein derivative (PPD) was investigated.
104 l myristate acetate (PMA) plus ionomycin, or purified protein derivative (PPD) was studied in vitro.
105 une response, elicited by Mycobacteria bovis purified protein derivative (PPD) was unaffected by CCR8
106                Recently, M. tuberculosis and purified protein derivative (PPD) were demonstrated to i
107 lin skin tests (induration, > or =5 mm) with purified protein derivative (PPD) were randomly assigned
108 because of the antigenic cross-reactivity of purified protein derivative (PPD) with M bovis BCG vacci
109 and interferon gamma production from healthy purified protein derivative (PPD)(+) donors.
110 coidosis patients compared with 0 of 11 (0%) purified protein derivative (PPD)(-) (P = 0.0059) and 4
111                   In the present study, Th1 (purified protein derivative (PPD)) and Th2 (schistosome
112 have long been detected by skin testing with purified protein derivative (PPD), a complex mix of part
113 TH to vaccine (P =.0001) but not with DTH to purified protein derivative (PPD), a control antigen.
114                    Phytohemagglutinin (PHA), purified protein derivative (PPD), and T cell epitope pe
115 ed in response to the mycobacterial antigens purified protein derivative (PPD), antigen 85, and manno
116 osis of both active and latent tuberculosis, purified protein derivative (PPD), lacks specificity and
117 pment of pulmonary granulomas in response to purified protein derivative (PPD), mice presensitized to
118 une competence was assessed by skin tests to purified protein derivative (PPD), mumps, and candida.
119  overnight in separate wells with tuberculin purified protein derivative (PPD), saline, and mitogen c
120 y (DTH) reaction to intradermal injection of purified protein derivative (PPD), we investigated the e
121  significantly augment the mycobacterial Ag, purified protein derivative (PPD)-driven lymphocyte prol
122               In addition, neither sera from purified protein derivative (PPD)-negative (0 of 29) nor
123 d HIV-positive, TB-positive patients but not purified protein derivative (PPD)-negative or PPD-positi
124    In contrast, nonadherent cells (NAC) from purified protein derivative (PPD)-positive and PPD-negat
125 th MDRTB were compared with those of healthy purified protein derivative (PPD)-positive and PPD-negat
126 Natural killer (NK) cells isolated from both purified protein derivative (PPD)-positive and PPD-negat
127                                           In purified protein derivative (PPD)-positive donors, PPD-s
128 ted for their ability to stimulate PBMC from purified protein derivative (PPD)-positive healthy donor
129 y approximately 50% when compared to healthy purified protein derivative (PPD)-positive household con
130  blood mononuclear cells (PBMC) from healthy purified protein derivative (PPD)-positive individuals o
131                                              Purified protein derivative (PPD)-specific immune recove
132 isease coincided with the restoration of BCG purified protein derivative (PPD)-specific T-cell immune
133                    At the time of diagnosis, purified protein derivative (PPD)-stimulated production
134 o Toll-like receptor (TLR)-2, -4 or -7/8, or purified protein derivative (PPD).
135 heir lack of dermal reactivity to tuberculin purified protein derivative (PPD).
136 uring both the 2-wk immunization period with purified protein-derivative (PPD) and the subsequent lun
137 77 years, HIV-1 seropositive, had a positive purified-protein derivative (PPD) skin test reaction of
138 ntigen and 2 tuberculosis-specific antigens (purified protein derivative [PPD] and ESAT-6/CFP10), fol
139 isease, and (iii) M. tuberculosis infection (purified protein derivative [PPD] positive) and no infec
140                                  Tuberculin (purified protein derivative [PPD])-induced lymphoprolife
141 soluble protein antigens of M. tuberculosis (purified protein derivative [PPD]).
142         Tetanus toxoid reactive clones and a purified protein derivative reactive line failed to resp
143                    In a study of 114 healthy purified protein derivative-reactive subjects and 89 pat
144 en both vaccines were administered together, purified protein derivative responses were enhanced in f
145 cells from healthy donors who had a positive purified protein derivative skin test but not from tuber
146          Immunization with BCG generated low purified protein derivative-specific CD4 T cell response
147                             We observed that purified protein derivative-specific human CD4(+) T lymp
148 cells coincided with increases in numbers of purified protein derivative-specific interferon- gamma -
149                            Adjusted rates of purified protein derivative testing and Papanicolaou sme
150 f IFN-gamma ELISPOT responses to recall Ags (purified protein derivative, Tetanus toxoid, or flu/EBV/
151 ovirus during the sensitization phase of the purified protein derivative Th1-type model significantly
152  and IL-12 were significantly reduced in the purified protein derivative Th1-type response, whereas I
153  more IFN-gamma in response to mycobacterial purified protein derivative than children of helminth-in
154 r recall Ags (influenza, n = 43, p < 0.0001; purified protein derivative tuberculin, n = 6, p = 0.029
155 d immune responses to mycobacterial antigen (purified protein derivative) were assayed using splenocy
156 enic target 6 (ESAT6) protein or tuberculin (purified protein derivative) with interferon-gamma ELISP

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top